ZA976247B - Antithrombotic pharmaceutical composition - Google Patents

Antithrombotic pharmaceutical composition

Info

Publication number: ZA976247B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical composition; antithrombotic pharmaceutical; antithrombotic; composition; pharmaceutical
Prior art date: 1996-07-26

Application number

ZA976247A

Other languages

English (en)

Inventor

Georges Daste

Jean-Marc Herbert

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-26

Filing date

1997-07-15

Publication date

1999-01-15

1997-07-15 Application filed by Sanofi Sa filed Critical Sanofi Sa

1999-01-15 Publication of ZA976247B publication Critical patent/ZA976247B/xx

Links

230000002785 anti-thrombosis Effects 0.000 title 1
239000003146 anticoagulant agent Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
- F16K41/00—Spindle sealings
- F16K41/02—Spindle sealings with stuffing-box ; Sealing rings
- F16K41/04—Spindle sealings with stuffing-box ; Sealing rings with at least one ring of rubber or like material between spindle and housing
- F16K41/043—Spindle sealings with stuffing-box ; Sealing rings with at least one ring of rubber or like material between spindle and housing for spindles which only rotate, i.e. non-rising spindles
- F16K41/046—Spindle sealings with stuffing-box ; Sealing rings with at least one ring of rubber or like material between spindle and housing for spindles which only rotate, i.e. non-rising spindles for rotating valves
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
- F02D—CONTROLLING COMBUSTION ENGINES
- F02D9/00—Controlling engines by throttling air or fuel-and-air induction conduits or exhaust conduits
- F02D9/04—Controlling engines by throttling air or fuel-and-air induction conduits or exhaust conduits concerning exhaust conduits
- F02D9/06—Exhaust brakes
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
- F16K1/00—Lift valves or globe valves, i.e. cut-off apparatus with closure members having at least a component of their opening and closing motion perpendicular to the closing faces
- F16K1/16—Lift valves or globe valves, i.e. cut-off apparatus with closure members having at least a component of their opening and closing motion perpendicular to the closing faces with pivoted closure-members
- F16K1/18—Lift valves or globe valves, i.e. cut-off apparatus with closure members having at least a component of their opening and closing motion perpendicular to the closing faces with pivoted closure-members with pivoted discs or flaps
- F16K1/22—Lift valves or globe valves, i.e. cut-off apparatus with closure members having at least a component of their opening and closing motion perpendicular to the closing faces with pivoted closure-members with pivoted discs or flaps with axis of rotation crossing the valve member, e.g. butterfly valves

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Mechanical Engineering (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Combustion & Propulsion (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA976247A 1996-07-26 1997-07-15 Antithrombotic pharmaceutical composition ZA976247B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9609474A FR2751540B1 (fr)	1996-07-26	1996-07-26	Composition pharmaceutique antithrombotique

Publications (1)

Publication Number	Publication Date
ZA976247B true ZA976247B (en)	1999-01-15

Family

ID=9494551

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA976247A ZA976247B (en)	1996-07-26	1997-07-15	Antithrombotic pharmaceutical composition

Country Status (34)

Country	Link
US (1)	US6218403B1 (de)
EP (1)	EP0914124B1 (de)
JP (1)	JP3553610B2 (de)
KR (1)	KR100307268B1 (de)
CN (1)	CN1109547C (de)
AR (1)	AR008782A1 (de)
AT (1)	ATE258052T1 (de)
AU (1)	AU725949B2 (de)
BR (1)	BR9710560B1 (de)
CA (1)	CA2261099C (de)
CZ (1)	CZ294664B6 (de)
DE (1)	DE69727299T2 (de)
DK (1)	DK0914124T3 (de)
EE (1)	EE03853B1 (de)
ES (1)	ES2214632T3 (de)
FR (1)	FR2751540B1 (de)
HU (1)	HU226245B1 (de)
ID (1)	ID17774A (de)
IL (1)	IL128102A0 (de)
IS (1)	IS2052B (de)
MY (1)	MY125051A (de)
NO (1)	NO322894B1 (de)
NZ (1)	NZ333826A (de)
PL (1)	PL188739B1 (de)
PT (1)	PT914124E (de)
RS (1)	RS49504B (de)
RU (1)	RU2176504C2 (de)
SI (1)	SI0914124T1 (de)
SK (1)	SK284944B6 (de)
TR (1)	TR199900154T2 (de)
TW (1)	TW442289B (de)
UA (1)	UA58518C2 (de)
WO (1)	WO1998004259A1 (de)
ZA (1)	ZA976247B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2769313B1 (fr) *	1997-10-06	2000-04-21	Sanofi Sa	Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
US7141602B2 (en) *	1998-09-18	2006-11-28	Lek Pharmaceuticals D.D.	Process for obtaining HMG-CoA reductase inhibitors of high purity
SI20109A (sl) *	1998-12-16	2000-06-30	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Stabilna farmacevtska formulacija
CA2470479A1 (en) *	2001-12-18	2003-06-26	Teva Pharmaceutical Industries Ltd.	Polymorphs of clopidogrel hydrogensulfate
US7074928B2 (en)	2002-01-11	2006-07-11	Teva Pharmaceutical Industries, Ltd.	Polymorphs of clopidogrel hydrogensulfate
AR040588A1 (es) *	2002-07-26	2005-04-13	Schering Corp	Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
US6800759B2 (en)	2002-08-02	2004-10-05	Teva Pharmaceutical Industries Ltd.	Racemization and enantiomer separation of clopidogrel
IL166593A0 (en)	2002-08-02	2006-01-15		Racemization and enantiomer separation of clopidogrel
DE602004029362D1 (de) *	2003-06-18	2010-11-11	Inst Cardiologie De Montreal M	Vermeidung von vorhofflimmern (af) mit der verwendung von statin
US6978908B2 (en) *	2003-09-15	2005-12-27	Gerber Products Company	Drinking vessel with adjustable handles
RU2261705C1 (ru) *	2004-01-29	2005-10-10	Медведев Илья Николаевич	Способ лечения тромбоцитопатии при метаболическом синдроме
KR100563455B1 (ko) *	2004-04-09	2006-03-23	한미약품 주식회사	결정성 클로피도그렐 나프탈렌술폰산염 또는 이의 수화물,이의 제조방법 및 이를 함유하는 약학적 조성물
SG165379A1 (en) *	2005-09-15	2010-10-28	Otsuka Pharma Co Ltd	Combination drug containing probucol and a tetrazolylalkoxy- dihydrocarbostyril derivative with superoxide supressant effects
US9532945B2 (en) *	2006-04-04	2017-01-03	Kg Acquisition Llc	Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
HUE040311T2 (hu) *	2006-04-04	2019-02-28	Kg Acquisition Llc	Vérlemezke aggregációt gátló szert és sav inhibitort tartalmazó orális dózisformák
EP1931682A2 (de) *	2006-08-03	2008-06-18	Teva Pharmaceutical Industries Ltd.	Verfahren zur herstellung von clopidogrel-bisulphat
WO2008060934A2 (en) *	2006-11-14	2008-05-22	Acusphere, Inc.	Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
EP2155168A2 (de) *	2007-04-09	2010-02-24	USV Limited	Stabile pharmazeutische zusammensetzungen von clopidogrel-bisulfat und herstellungsvefahren dafür
EP2148655B1 (de) *	2007-04-20	2013-02-27	Wockhardt Limited	Pharmazeutische zusammensetzungen von clopidogrel
US8343995B2 (en) *	2007-04-27	2013-01-01	Cydex Pharmaceuticals, Inc.	Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
EP2303233B1 (de) *	2008-07-25	2012-06-20	Pharmathen S.A.	Den thrombozytenaggregationshemmer clopidogrel enthaltende feste orale dosierform und herstellungsverfahren dafür
RU2396079C1 (ru) *	2008-12-03	2010-08-10	Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) (статус государственного учреждения)	Лекарственное средство с гиполипидемическим эффектом "аторваглизин"
EA021588B1 (ru)	2009-06-25	2015-07-30	Тетра Сиа	Бетаиновые соли ацетилсалициловой кислоты
JP2020507621A (ja)	2017-01-23	2020-03-12	ドンファファーマシューティカルカンパニーリミテッド	ＨＭＧ−ＣｏＡ還元酵素阻害剤およびクロピドグレルを含む複合製剤
CN118185711A (zh) *	2024-02-28	2024-06-14	湖北兴福电子材料股份有限公司	一种铜钴钨兼容性好的TiN去除组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2003478A1 (en) *	1988-12-12	1990-06-12	Leonard G. Dennick	Combination of an hmg coa reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
FR2665440B1 (fr) *	1990-07-31	1994-02-04	Lipha	Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
WO1995011898A1 (en) *	1992-05-12	1995-05-04	Nissan Chemical Industries Ltd.	Condensed pyridine type mevalonolactone intermediate and process for its production
WO1995013063A1 (en) *	1993-11-09	1995-05-18	Merck & Co., Inc.	HMG-CoA REDUCTASE INHIBITORS IN THE NORMALIZATION OF VASCULAR ENDOTHELIAL DYSFUNCTION
US5945432A (en) *	1995-12-22	1999-08-31	The University Of Vermont And State Agricultural College	Thrombolytic agents and thienopyridine derivatives in acute stroke

1996
- 1996-07-26 FR FR9609474A patent/FR2751540B1/fr not_active Expired - Fee Related
1997
- 1997-07-15 ZA ZA976247A patent/ZA976247B/xx unknown
- 1997-07-15 TW TW086110010A patent/TW442289B/zh not_active IP Right Cessation
- 1997-07-18 AR ARP970103243A patent/AR008782A1/es active IP Right Grant
- 1997-07-21 AU AU38526/97A patent/AU725949B2/en not_active Ceased
- 1997-07-21 HU HU9903752A patent/HU226245B1/hu not_active IP Right Cessation
- 1997-07-21 CZ CZ1999176A patent/CZ294664B6/cs not_active IP Right Cessation
- 1997-07-21 EP EP97935593A patent/EP0914124B1/de not_active Expired - Lifetime
- 1997-07-21 CN CN97197539A patent/CN1109547C/zh not_active Expired - Fee Related
- 1997-07-21 RU RU99103623/14A patent/RU2176504C2/ru not_active IP Right Cessation
- 1997-07-21 TR TR1999/00154T patent/TR199900154T2/xx unknown
- 1997-07-21 UA UA99021085A patent/UA58518C2/uk unknown
- 1997-07-21 BR BRPI9710560-0B1A patent/BR9710560B1/pt not_active IP Right Cessation
- 1997-07-21 DE DE69727299T patent/DE69727299T2/de not_active Expired - Lifetime
- 1997-07-21 IL IL12810297A patent/IL128102A0/xx not_active IP Right Cessation
- 1997-07-21 PT PT97935593T patent/PT914124E/pt unknown
- 1997-07-21 PL PL97331339A patent/PL188739B1/pl unknown
- 1997-07-21 ES ES97935593T patent/ES2214632T3/es not_active Expired - Lifetime
- 1997-07-21 RS YU3199A patent/RS49504B/sr unknown
- 1997-07-21 EE EEP199900028A patent/EE03853B1/xx not_active IP Right Cessation
- 1997-07-21 SI SI9730622T patent/SI0914124T1/xx unknown
- 1997-07-21 WO PCT/FR1997/001353 patent/WO1998004259A1/fr not_active Ceased
- 1997-07-21 CA CA002261099A patent/CA2261099C/fr not_active Expired - Fee Related
- 1997-07-21 SK SK78-99A patent/SK284944B6/sk not_active IP Right Cessation
- 1997-07-21 AT AT97935593T patent/ATE258052T1/de active
- 1997-07-21 US US09/230,299 patent/US6218403B1/en not_active Expired - Lifetime
- 1997-07-21 NZ NZ333826A patent/NZ333826A/xx not_active IP Right Cessation
- 1997-07-21 JP JP50854598A patent/JP3553610B2/ja not_active Expired - Fee Related
- 1997-07-21 DK DK97935593T patent/DK0914124T3/da active
- 1997-07-24 ID IDP972577A patent/ID17774A/id unknown
- 1997-07-25 MY MYPI97003383A patent/MY125051A/en unknown
1999
- 1999-01-22 IS IS4951A patent/IS2052B/is unknown
- 1999-01-22 KR KR1019997000501A patent/KR100307268B1/ko not_active Expired - Fee Related
- 1999-01-25 NO NO19990321A patent/NO322894B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
RU2176504C2 (ru)	2001-12-10
AU725949B2 (en)	2000-10-26
ATE258052T1 (de)	2004-02-15
CN1109547C (zh)	2003-05-28
NO322894B1 (no)	2006-12-18
NZ333826A (en)	2000-09-29
CA2261099A1 (fr)	1998-02-05
PT914124E (pt)	2004-05-31
PL188739B1 (pl)	2005-04-29
HU226245B1 (en)	2008-07-28
MY125051A (en)	2006-07-31
BR9710560B1 (pt)	2013-12-03
TW442289B (en)	2001-06-23
SI0914124T1 (en)	2004-06-30
SK7899A3 (en)	1999-07-12
PL331339A1 (en)	1999-07-05
IL128102A0 (en)	1999-11-30
IS4951A (is)	1999-01-22
FR2751540A1 (fr)	1998-01-30
CN1228698A (zh)	1999-09-15
NO990321D0 (no)	1999-01-25
KR100307268B1 (ko)	2001-09-24
YU3199A (sh)	2002-09-19
CA2261099C (fr)	2003-04-15
EE03853B1 (et)	2002-10-15
UA58518C2 (uk)	2003-08-15
FR2751540B1 (fr)	1998-10-16
JP3553610B2 (ja)	2004-08-11
HUP9903752A2 (hu)	2000-03-28
SK284944B6 (sk)	2006-03-02
US6218403B1 (en)	2001-04-17
HUP9903752A3 (en)	2001-12-28
EE9900028A (et)	1999-08-16
AU3852697A (en)	1998-02-20
CZ294664B6 (cs)	2005-02-16
AR008782A1 (es)	2000-02-23
WO1998004259A1 (fr)	1998-02-05
JP2000500781A (ja)	2000-01-25
CZ17699A3 (cs)	1999-05-12
EP0914124A1 (de)	1999-05-12
NO990321L (no)	1999-03-22
DE69727299D1 (de)	2004-02-26
TR199900154T2 (xx)	1999-04-21
BR9710560A (pt)	1999-08-17
RS49504B (sr)	2006-10-27
IS2052B (is)	2005-10-14
DE69727299T2 (de)	2004-10-21
ID17774A (id)	1998-01-29
ES2214632T3 (es)	2004-09-16
HK1019405A1 (en)	2000-02-11
EP0914124B1 (de)	2004-01-21
DK0914124T3 (da)	2004-05-17
KR20000029484A (ko)	2000-05-25

Publication	Publication Date	Title
EG24118A (en)	2008-07-06	Pharmaceutical compositions
EP0943327A4 (de)	2003-06-25	Arzneimittel
GB9616672D0 (en)	1996-09-25	Pharmaceutical compositions
ZA9710006B (en)	1999-06-05	Novel pharmaceutical compositions
EP0755250A4 (de)	2000-04-19	Benzamid enthaltende pharmazeutische zusammensetzungen
GB9610359D0 (en)	1996-07-24	Pharmaceutical compositions
GB9622681D0 (en)	1997-01-08	Pharmaceutical compositions
GB9606429D0 (en)	1996-06-05	Pharmaceutical compositions
GB9623962D0 (en)	1997-01-08	Pharmaceutical composition
GB9613457D0 (en)	1996-08-28	Pharmaceutical compositions
GB9406835D0 (en)	1994-06-01	Pharmaceutical compositions
GB2295825B (en)	1997-01-29	Pharmaceutical compositions
GB9610136D0 (en)	1996-07-24	Pharmaceutical compositions
GB9618376D0 (en)	1996-10-16	Pharmaceutical compositions
GB9400047D0 (en)	1994-03-02	Pharmaceutical compositions
GB2308545A (en)	1997-07-02	Pharmaceutical compositions
ZA962792B (en)	1996-12-31	Pharmaceutical composition
GB9615627D0 (en)	1996-09-04	Pharmaceutical composition
GB9611530D0 (en)	1996-08-07	Pharmaceutical composition
GB9626185D0 (en)	1997-02-05	Pharmaceutical composition
GB9620048D0 (en)	1996-11-13	Pharmaceutical composition
GB9606586D0 (en)	1996-06-05	Pharmaceutical compositions
GB9603942D0 (en)	1996-04-24	Pharmaceutical compositions
HU9400523D0 (en)	1994-05-30	Pharmaceutical composition
GB9424470D0 (en)	1995-01-18	Pharmaceutical composition